Citigroup »

Sage Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 124k 21.71
2023-09-30 $3.6M 177k 20.50
2023-03-31 $7.3M 174k 41.96
2022-12-31 $5.4M 142k 38.14
2022-09-30 $8.6M 172k 50.00
2021-12-31 $10M 238k 42.54
2021-03-31 $6.3M 84k 74.55
2020-12-31 $8.5M 98k 87.09
2020-09-30 $3.7M 60k 61.70
2020-06-30 $0 105k 0.00
2020-03-31 $3.1M 107k 28.72
2019-12-31 $13M 182k 72.19
2019-09-30 $15M 105k 140.29
2019-06-30 $21M 115k 183.08
2019-03-31 $20M 124k 159.05
2018-12-31 $15M 152k 95.78
2018-09-30 $18M 127k 141.25
2018-06-30 $15M 98k 156.54
2018-03-31 $14M 84k 161.07
2017-12-31 $21M 127k 164.72
2017-09-30 $4.5M 73k 62.29
2017-06-30 $8.7M 109k 79.63
2017-03-31 $15M 212k 71.07
2016-12-31 $13M 248k 51.06
2016-09-30 $5.9M 129k 46.05
2016-06-30 $258k 8.6k 30.14
2015-12-31 $455k 7.8k 58.35
2015-09-30 $747k 18k 42.34
2015-06-30 $728k 10k 72.99
2014-09-30 $6.0k 201 29.85